- Filed
- Mar 28, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2023 · Mar 26, 2024 | 2.86M sh |
| Shares Diluted | FY 2023 · Dec 31, 2022 | 2.86M sh |
| Stock Repurchased | FY 2023 · Dec 31, 2022 | $21K |
| Capex | FY 2023 · Dec 31, 2022 | $67K |
| Operating Cash Flow | FY 2023 · Dec 31, 2022 | $2.71M |
| Short Term Investments restated | FY 2023 · Dec 31, 2022 | $5.24M |
| Cash And Equivalents | FY 2023 · Dec 31, 2022 | $9.46M |
| Stockholders Equity | FY 2023 · Dec 31, 2022 | $33.32M |
| Total Liabilities | FY 2023 · Dec 31, 2022 | $7.68M |
| Total Assets | FY 2023 · Dec 31, 2022 | $41.1M |
| Eps Diluted | FY 2023 · Dec 31, 2022 | $1.31 |
| Eps Basic | FY 2023 · Dec 31, 2022 | $1.31 |
| Sga Expense | FY 2023 · Dec 31, 2022 | $10.24M |
| Net Income | FY 2023 · Dec 31, 2022 | $3.74M |
| Gross Profit | FY 2023 · Dec 31, 2022 | $14.07M |
| Cost Of Revenue | FY 2023 · Dec 31, 2022 | $408K |
| Revenue | FY 2023 · Dec 31, 2022 | $14.48M |